Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Xbiotech Advances With Positive Data

|Includes: Xbiotech (XBIT)

Following my article last month Xbiotech XBIT to present at the 18th European Society of Medical Oncology's World Congress positive preliminary survival data.

According to their press release from today, the data from their European Phase III trial show a positive correlation with overall survival. More details to follow at the congress by the end of June.

Disclosure: I am/we are long XBIT.